Main Main Main


Deals for Actavis, Teva plants put G&W in the spotlight; CEO says its culture is its beacon

G&W Laboratories, a small generic drugmaker, recently broke onto the pharma scene publicly with two substantial deals in 10 months for plants and products.

G&W Appoints Aaron Greenblatt as Chief Executive Officer

March 12, 2015 -- South Plainfield, NJ – The Board of Directors of G&W Laboratories has appointed Dr. Aaron Greenblatt as its new Chief Executive Officer.

Teva Sells Pennsylvania Facility to G&W Laboratories

Teva Pharmaceutical Industries Ltd. has agreed to sell its Pennsylvania facilities to G&W Laboratories Inc. as part of the Israeli company's cost-reduction program.

G&W Laboratories buying Teva plant after picking up one from Actavis

For the second time in about 9 months, a privately held New Jersey company has saved a manufacturing plant from closing and hundreds of jobs from being lost.